BioRestorative Therapies (BRTX) executive Alstodt bought 300 shares for $903 at an average $3.01

Insider transactions reported

Lance Alstodt (executive at BioRestorative Therapies Inc., BRTX) reported that they bought 300 shares for $903 at an average $3.01 on Dec 23, 2022. After these transactions the filing shows 186,021 shares held directly.

Reporting person

Alstodt Lance

Holdings before and after

• Common Stock: 185,721 to 186,021 direct

Footnotes from the filing

1. 1. Includes 100,935 shares received pursuant to an unvested restricted stock unit grant. Such shares vest to the extent of 1,036 shares on January 18, 2023, 1,037 shares on February 18, 2023, 49,949 shares on March 18, 2023 and 48,913 shares on March 18, 2024.
2. 2. The option vests and becomes exercisable to the extent of 146,740 shares on March 18, 2021, 36,684 shares on November 4, 2021 with the remaining 110,055 shares in six nearly equal quarterly installments beginning December 18, 2021 and continuing every three months thereafter until fully vested.
3. 3. The option vests and becomes exercisable to the extent of 21,030 shares on November 4, 2021 with the remaining 21,029 shares vesting quarterly in eight nearly equal installments beginning on November 4, 2022.

Transaction codes in this filing

Open-market purchase:

Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

FAQ